Literature DB >> 28274181

Structure of the carboxypeptidase B complex with N-sulfamoyl-L-phenylalanine - a transition state analog of non-specific substrate.

Valery Akparov1, Vladimir Timofeev2,3, Ilyas Khaliullin4, Vytas Švedas5, Inna Kuranova2,3.   

Abstract

Carboxypeptidase B (EC 3.4.17.2) (CPB) is commonly used in the industrial insulin production and as a template for drug design. However, its ability to discriminate substrates with hydrophobic, hydrophilic, and charged side chains is not well understood. We report structure of CPB complex with a transition state analog N-sulfamoyl-L-phenylalanine solved at 1.74Å. The study provided an insight into structural basis of CPB substrate specificity. Ligand binding is affected by structure-depended conformational changes of Asp255 in S1'-subsite, interactions with Asn144 and Arg145 in C-terminal binding subsite, and Glu270 in the catalytic center. Side chain of the non-specific substrate analog SPhe in comparison with that of specific substrate analog SArg (reported earlier) not only loses favorable electrostatic interactions and two hydrogen bonds with Asp255 and three fixed water molecules, but is forced to be in the unfavorable hydrophilic environment. Thus, Ser207, Gly253, Tyr248, and Asp255 residues play major role in the substrate recognition by S1'-subsite.

Entities:  

Keywords:  N-sulfamoyl-L-Phenylalanine; X-ray analysis; carboxypeptidase B; substrate selectivity determinants; transition state complex

Mesh:

Substances:

Year:  2017        PMID: 28274181     DOI: 10.1080/07391102.2017.1304242

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  1 in total

1.  The nature of the ligand's side chain interacting with the S1'-subsite of metallocarboxypeptidase T (from Thermoactinomyces vulgaris) determines the geometry of the tetrahedral transition complex.

Authors:  Valery Kh Akparov; Vladimir I Timofeev; Galina E Konstantinova; Ilyas G Khaliullin; Inna P Kuranova; Tatiana V Rakitina; Vytas Švedas
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.